المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المصدر: Ivanova , S A , Alifirova , V M , Pozhidaev , I V , Fedorenko , O Y , Osmanova , D Z , Tiguntsev , V V , Bokhan , N A , Zhukova , I A , Wilffert , B & Loonen , A J M 2016 , ' CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias ' , European Neuropsychopharmacology , vol. 26 , pp. S656-S657 .

مصطلحات موضوعية: antioxidant, catechol methyltransferase, cytochrome P450 2D6, dopamine, endogenous compound, levodopa, methionine, neurotransmitter, neurotransmitter receptor, phosphodiesterase I, Abnormal Involuntary Movement Scale, adverse drug reaction, clinical trial, codon, data analysis software, disease carrier, disease duration, DNA extraction, dopamine uptake, drug therapy, gene frequency, genetic susceptibility, genotype, human, levodopa-induced dyskinesia, major clinical study, missense mutation, monoamine metabolism, odds ratio, onset age

العلاقة: https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2Test

الإتاحة: https://hdl.handle.net/11370/014e8ece-6d80-4997-9468-60cc28f28dd2Test
https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2Test

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المساهمون: Methods in Medicines evaluation & Outcomes research (M2O), Reproductive Origins of Adult Health and Disease (ROAHD), PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

المصدر: ResearcherID
European Neuropsychopharmacology, 26, S656-S657. ELSEVIER SCIENCE BV

مصطلحات موضوعية: onset age, antioxidant, side effect, endogenous compound, phenotype, neurotransmitter receptor, genotype, adverse drug reaction, prevalence, gene frequency, disease carrier, statistical analysis, single nucleotide polymorphism, dopamine uptake, odds ratio, oxidative stress, human, levodopa, DNA extraction, cytochrome P450 2D6, Abnormal Involuntary Movement Scale, methionine, phosphodiesterase I, data analysis software, missense mutation, levodopa-induced dyskinesia, treatment response, clinical trial, visually impaired person, major clinical study, drug therapy, monoamine metabolism, Parkinson disease, catechol methyltransferase, substitution reaction, dopamine, codon, disease duration, neurotransmitter, genetic susceptibility

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08382109854c93ef19f47098e58d290cTest
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000398568302345&KeyUID=WOS:000398568302345Test

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المصدر: European Neuropsychopharmacology. Oct2016 Supplement 2, Vol. 26, pS656-S657. 1p.

مصطلحات موضوعية: *CATECHOL-O-methyltransferase gene, *GENETIC polymorphisms, *PARKINSON'S disease patients, *DOPA, *DYSKINESIAS, *DRUG side effects